Table 5 Multivariate analysis of variance (MANOVA) for the relationship between carnitine compounds and clinicopathological aspects of HCC
Clinical-pathological aspect of HCC | Pillai’s trace | F-statistic | Significance |
|---|---|---|---|
Intercept | 0.939 | 47.740b | 0.000 |
Gender | 0.274 | 1.177b | 0.315 |
PVT | 0.148 | 0.542b | 0.917 |
CPC | 0.322 | 1.481b | 0.138 |
BCLC | 0.292 | 1.285b | 0.238 |
NFL | 0.237 | 0.969b | 0.505 |
Gender × PVT | 0.000 | .b | |
Gender × CPC | 0.302 | 1.347b | 0.201 |
Gender × BCLC | 0.000 | .b | |
Gender × NFL | 0.000 | .b | |
PVT × CPC | 0.000 | .b | |
PVT × BCLC | 0.000 | .b | |
PVT × NFL | 0.139 | 0.505b | 0.939 |
CPC × BCLC | 0.216 | 0.858b | 0.622 |
CPC × NFL | 0.227 | 0.916b | 0.560 |
BCLC × NFL | 0.240 | 0.982b | 0.491 |
Gender × PVT × CPC | 0.000 | .b | |
Gender × PVT × BCLC | 0.000 | .b | |
Gender × PVT × NFL | 0.000 | .b | |
Gender × CPC × BCLC | 0.000 | .b | |
Gender × CPC × NFL | 0.000 | .b | |
Gender × BCLC × NFL | 0.000 | .b | |
PVT × CPC × BCLC | 0.000 | .b | |
PVT × CPC × NFL | 0.000 | .b | |
PVT × BCLC × NFL | 0.000 | .b | |
CPC × BCLC × NFL | 0.270 | 1.150b | 0.336 |
Gender × PVT × CPC × BCLC | .000 | .b | |
Gender × PVT × CPC × NFL | .000 | .b | |
Gender × PVT × BCLC × NFL | .000 | .b | |
Gender × CPC × BCLC × NFL | .000 | .b | |
PVT × CPC × BCLC × NFL | .000 | .b | |
Gender × PVT × CPC × BCLC × NFL | .000 | .b |